IN THIS ARTICLE
Cardiomyopathy is a prevalent disease. In the United States, up to a half million people develop a dilated cardiomyopathy every year. Ischemic cardiomyopathy may be present in up to 1% of the population. Because cardiomyopathy tends to be progressive, mortality depends upon the amount of heart pumping function loss; and one goal of therapy is to slow the rate of this loss.
Research on new medical and surgical treatments continues, ranging from new medications, stem cell research, and innovative types of implantable heart assist devices. Ongoing clinical trials for patients with cardiomyopathies are being conducted by the National Institutes of Health.
Medically reviewed by Robert J. Bryg, MD; Board Certified Internal Medicine with subspecialty in Cardiovascular Disease
Medically Reviewed by a Doctor on 11/30/2015
YOU MAY ALSO LIKE
Must Read Articles Related to Cardiomyopathy
Healthy Heart Resources
- Early Care for Your Premature Baby
- What to Eat When You Have Cancer
- When to Take More Pain Medication